Abbott Laboratories (ABT)

Operating return on assets (Operating ROA)

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Operating income (ttm) US$ in thousands 7,787,000 7,548,000 7,182,000 6,879,000 6,753,000 6,613,000 6,438,000 6,453,000 6,030,000 6,055,000 6,877,000 8,362,000 9,368,000 10,287,000 9,952,000 9,200,000 9,167,000 8,001,000 6,645,000 5,291,000
Total assets US$ in thousands 84,181,000 83,999,000 81,448,000 81,414,000 74,356,000 73,017,000 72,467,000 73,214,000 72,090,000 73,354,000 73,794,000 74,438,000 72,801,000 74,202,000 74,007,000 75,196,000 73,795,000 73,269,000 72,785,000 72,548,000
Operating ROA 9.25% 8.99% 8.82% 8.45% 9.08% 9.06% 8.88% 8.81% 8.36% 8.25% 9.32% 11.23% 12.87% 13.86% 13.45% 12.23% 12.42% 10.92% 9.13% 7.29%

September 30, 2025 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $7,787,000K ÷ $84,181,000K
= 9.25%


Peer comparison

Sep 30, 2025

Company name
Symbol
Operating ROA
Abbott Laboratories
ABT
9.25%
CONMED Corporation
CNMD
5.10%
Stryker Corporation
SYK
11.78%